Cargando…

Beta-Blockers for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: An Updated Meta-Analysis of Randomized Clinical Trials

AIM: Cardiotoxicity is a well-recognized complication of chemotherapy with Anthracyclines. However, results from trials evaluating beta-blockers for prevention are controversial. Therefore, we performed a meta-analysis to find whether prophylactic administration of beta-blockers can help prevent Ant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attar, Armin, Behnagh, Arman Karimi, Hosseini, Mehrasa, Amanollahi, Foad, Shafiekhani, Paria, Kabir, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818032/ https://www.ncbi.nlm.nih.gov/pubmed/36687509 http://dx.doi.org/10.1155/2022/8367444

Ejemplares similares

Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study
por: Yahyavi, Ashkan, et al.
Publicado: (2020)

Preventive use of beta-blockers for anthracycline-induced cardiotoxicity: A network meta-analysis
por: He, Dongsheng, et al.
Publicado: (2022)

Sildenafil for Primary Prevention of Anthracycline-Induced Cardiac Toxicity: A Phase I/II Randomized Clinical Trial, SILDAT-TAHA6 Trial
por: Attar, Armin, et al.
Publicado: (2022)

Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
por: Ma, Yingxu, et al.
Publicado: (2019)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Selenium in the Prevention of Anthracycline-Induced Cardiac Toxicity in Children with Cancer
por: Tacyildiz, Nurdan, et al.
Publicado: (2012)

Evaluation of the Association between Fetal Cardiac Disorders with Choroid Plexus Cyst in Fetuses
por: Dakkali, Mohammad Sedigh, et al.
Publicado: (2022)

Comparative Cardiac Toxicity of Anthracyclines In Vitro and In Vivo in the Mouse
por: Toldo, Stefano, et al.
Publicado: (2013)

Cardiac Toxicity and Anthracyclines: Mechanism, Interventions, and the Trouble With Troponin
por: Thompson, Grace E., et al.
Publicado: (2019)

Circulating hemopexin modulates anthracycline cardiac toxicity in patients and in mice
por: Liu, Jing, et al.
Publicado: (2022)

Multicenter, Prospective, Randomized Controlled Trial of High-Sensitivity Cardiac Troponin I–Guided Combination Angiotensin Receptor Blockade and Beta-Blocker Therapy to Prevent Anthracycline Cardiotoxicity: The Cardiac CARE Trial
por: Henriksen, Peter A., et al.
Publicado: (2023)

Beta-Blocker and Calcium Channel Blocker Toxicity With BRASH Syndrome: A Case Report
por: Martinez, Adolfo, et al.
Publicado: (2023)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Radiotherapy and anthracyclines – cardiovascular toxicity
por: Mozdzanowska, Dagmara, et al.
Publicado: (2014)

Cardiac toxicity of chemotherapy for breast cancer: do angiotensin-converting enzyme inhibitors and beta blockers protect?
por: Bisceglia, Irma, et al.
Publicado: (2023)

The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
por: Ayuna, Ahmed, et al.
Publicado: (2020)

High dose insulin therapy, an evidence based approach to beta blocker/calcium channel blocker toxicity
por: Woodward, Christina, et al.
Publicado: (2014)

Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view
por: Wołowiec, Łukasz, et al.
Publicado: (2023)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Inhibition of Rac1 signaling by lovastatin protects against anthracycline-induced cardiac toxicity
por: Huelsenbeck, J, et al.
Publicado: (2011)

Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells
por: Vavrova, Anna, et al.
Publicado: (2013)

Radiation- and anthracycline-induced cardiac toxicity and the influence of ErbB2 blocking agents
por: Seemann, Ingar, et al.
Publicado: (2013)

A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity
por: Yang, Xinyu, et al.
Publicado: (2018)

Anthracycline‑induced delayed‑onset cardiac toxicity: A case report and literature review
por: Kong, Mowei, et al.
Publicado: (2023)

New Insights into Cardiac and Brain Sodium Channels Modulation by Beta Blockers
por: Chahine, Mohamed
Publicado: (2011)

High anthracycline cumulative dose without cardiac toxicity: A possible protective role of morphine
por: Canale, Maria Laura, et al.
Publicado: (2018)

Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review
por: Abolmaali, Meysam, et al.
Publicado: (2022)

A Clinical-Epidemiological Study on Beta-Blocker Poisonings Based on the Type of Drug Overdose
por: Eizadi-Mood, Nastaran, et al.
Publicado: (2023)

Perioperative use of beta-blockers
por: Priebe, Hans-Joachim
Publicado: (2009)

Beta-blockers in liver cirrhosis
por: Giannelli, Valerio, et al.
Publicado: (2014)

Anthracycline-induced toxicity affecting palmar and plantar skin.
por: Jones, A. P., et al.
Publicado: (1989)

Toxicity, outcome, and management of anthracycline overdoses in 16 dogs
por: Lawson, Haylie C., et al.
Publicado: (2021)

Effect of short-acting beta blocker on the cardiac recovery after cardiopulmonary bypass
por: Sun, Jie, et al.
Publicado: (2011)

Current patterns of beta‐blocker prescription in cardiac amyloidosis: an Italian nationwide survey
por: Tini, Giacomo, et al.
Publicado: (2021)

Assessment of normal hemodynamic profile of mechanical pulmonary prosthesis by doppler echocardiography: a prospective cross-sectional study
por: Shojaeifard, Maryam, et al.
Publicado: (2020)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
por: Mabudian, Leila, et al.
Publicado: (2022)

Calcium-Channel Blockers: An Alternative Therapy to Beta-Blockers for Myocardial Infarction?
por: Hao, Kiyotaka, et al.
Publicado: (2023)

Melatonin effect on platelets and coagulation: Implications for a prophylactic indication in COVID-19
por: Hosseinzadeh, Azam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4t0rn7f5u2g0110der8n78mkbo